GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psychemedics Corp (NAS:PMD) » Definitions » Cyclically Adjusted Price-to-FCF

Psychemedics (Psychemedics) Cyclically Adjusted Price-to-FCF : 4.85 (As of May. 22, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Psychemedics Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), Psychemedics's current share price is $2.6184. Psychemedics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.54. Psychemedics's Cyclically Adjusted Price-to-FCF for today is 4.85.

The historical rank and industry rank for Psychemedics's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

PMD' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 4.08   Med: 20.48   Max: 49
Current: 4.89

During the past years, Psychemedics's highest Cyclically Adjusted Price-to-FCF was 49.00. The lowest was 4.08. And the median was 20.48.

PMD's Cyclically Adjusted Price-to-FCF is ranked better than
93.55% of 62 companies
in the Medical Diagnostics & Research industry
Industry Median: 36.77 vs PMD: 4.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Psychemedics's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-0.083. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.54 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Psychemedics Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Psychemedics's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psychemedics Cyclically Adjusted Price-to-FCF Chart

Psychemedics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.88 9.79 13.97 8.18 6.07

Psychemedics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.77 8.16 7.62 6.07 5.47

Competitive Comparison of Psychemedics's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Psychemedics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psychemedics's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Psychemedics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Psychemedics's Cyclically Adjusted Price-to-FCF falls into.



Psychemedics Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Psychemedics's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=2.6184/0.54
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psychemedics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Psychemedics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.083/131.7762*131.7762
=-0.083

Current CPI (Mar. 2024) = 131.7762.

Psychemedics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.727 100.560 -0.953
201409 0.088 100.428 0.115
201412 0.373 99.070 0.496
201503 0.051 99.621 0.067
201506 0.123 100.684 0.161
201509 -0.054 100.392 -0.071
201512 0.393 99.792 0.519
201603 -0.009 100.470 -0.012
201606 0.313 101.688 0.406
201609 0.562 101.861 0.727
201612 0.438 101.863 0.567
201703 0.730 102.862 0.935
201706 -0.244 103.349 -0.311
201709 0.630 104.136 0.797
201712 0.307 104.011 0.389
201803 0.227 105.290 0.284
201806 0.343 106.317 0.425
201809 -0.037 106.507 -0.046
201812 0.682 105.998 0.848
201903 0.043 107.251 0.053
201906 0.198 108.070 0.241
201909 0.164 108.329 0.199
201912 0.071 108.420 0.086
202003 -0.159 108.902 -0.192
202006 -0.663 108.767 -0.803
202009 -0.316 109.815 -0.379
202012 0.219 109.897 0.263
202103 -0.082 111.754 -0.097
202106 0.109 114.631 0.125
202109 -0.081 115.734 -0.092
202112 0.096 117.630 0.108
202203 0.053 121.301 0.058
202206 0.051 125.017 0.054
202209 0.398 125.227 0.419
202212 0.330 125.222 0.347
202303 -0.047 127.348 -0.049
202306 -0.178 128.729 -0.182
202309 -0.173 129.860 -0.176
202312 0.110 129.419 0.112
202403 -0.083 131.776 -0.083

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Psychemedics  (NAS:PMD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Psychemedics Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Psychemedics's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Psychemedics (Psychemedics) Business Description

Traded in Other Exchanges
N/A
Address
289 Great Road, Suite 200, Acton, MA, USA, 01720
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. Geographically it generates the majority of its revenue from the United States.
Executives
Shannon Shoemaker officer: Chief Revenue Officer 289 GREAT ROAD, SUITE 200, ACTON MA 01720
Charles M Doucot officer: Executive Vice President 289 GREAT ROAD, SUITE 200, ACTON MA 01720
Andrew Reynolds director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Brian Hullinger director, officer: President & CEO 289 GREAT ROAD, SUITE 200, ACTON MA 01720
Robyn C Davis director ONE WALLINGFORD ROAD, MARBLEHEAD MA 01945
Michael Weisenhoff other: Assistant Controller 289 GREAT ROAD, SUITE 200, ACTON MA 01720
Michael I Schaffer officer: VP of Laboratory Operations C/O PAYCHEMEDICS CORP, 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
William B. Norris other: Assistant Controller 289 GREAT ROAD, SUITE 200, ACTON MA 01720
Darius G Nevin other: See Footnote 1 C/O WCI COMMUNITIES, INC., 24301 WALDEN CENTER DRIVE, BONITA SPRINGS FL 34134
Peter H Kamin 10 percent owner 2720 DONALD ROSS ROAD, #311, PALM BEACH GARDENS FL 33410
Andrew Limbek officer: Vice President & Controller 289 GREAT ROAD, SUITE 200, ACTON MA 01720
Fred J Weinert director 330 E MAIN ST, BARRINGTON IL 60620
Kubacki Raymond C Jr director, officer: Chairman, CEO & President 125 NAGOG PARK, ACTON MA 01720
A Clinton Allen director, officer: Chairman 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
Neil Lerner officer: VP - Finance C/O PSYCHEMEDICS CORPORATION, 125 NAGOG PARK, ACTON MA 01720